SFJAZZ.org | Bruce Cozadd Bio


Bruce Cozadd

Bruce Cozadd - (Vice Chair) - 3rd Term

Bruce Cozadd co-founded Jazz Pharmaceuticals in 2003 and has served as the Company’s chairman since founding, and as CEO since April 2009. From 1991 until 2001, he held various positions with ALZA Corporation, a pharmaceutical company acquired by Johnson & Johnson, including EVP and COO. He also served as CFO and VP Corporate Planning/Analytics at ALZA. Mr. Cozadd is a member of the board of Biotechnology Innovation Organization (BIO), a biotechnology trade association, where he serves on the Health Section Governing Board. Mr. Cozadd also serves on the boards of biopharma company, ACELYRIN and The Nueva School as well as SFJAZZ. He received a B.S. from Yale University with a double major in molecular biophysics and biochemistry and economics and an M.B.A. from the Stanford Graduate School of Business.

Back To Trustees

We use cookies on our site to improve your experience. To find out more, view our Terms of Use and Privacy Policy for more details.